PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models (Q34627931)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q24851696)
(P304) 635-642
(P407) (Q1860)
(P433) 4
(P478) 104
(P577) Tuesday, February 1, 2011
(P921) (Q574834)
(P1433) (Q326309)
(P1476) "PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models" (language: en)
(P2093) K Dredge
E Hammond
P Handley
T J Gonda
C Vincent
R Brandt
V Ferro
I Bytheway
(P2860) (Q30410564)
(Q37802953)
(Q34398151)
(Q38346727)
(Q39862444)
(Q29614537)
(Q24608039)
(Q37403323)
(Q39936985)
(Q36407511)
(Q29614538)
(Q36752653)
(Q33372757)
(Q36414904)
(Q24303327)
(Q29614539)
(Q29615445)
(Q40435873)
(Q29617585)
(Q34098843)
(Q41724143)
(Q41140266)
(Q38313060)
(Q28294717)
(Q46860348)
(Q44304195)
(Q44772596)
(Q53188820)
(Q44027171)
(Q58814483)
(Q81934731)
(Q80741220)
other details
description scientific article

External Links